Suvretta Capital Management »

Crh shares owned by Suvretta Capital Management

Quarter-by-quarter ownership of Crh (CRH) shares owned by Suvretta Capital Management from 13F filings

Historical chart of Suvretta Capital Management investment in Crh

Tip: Access up to 7 years of quarterly data

All positions including Crh held by Suvretta Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crh by Suvretta Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $32M 432k 74.98
2024-03-31 $29M 336k 86.26

More positions owned by Suvretta Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Biohaven (BHVN)
Insmed Com Par $.01 (INSM)
Kura Oncology (KURA)
Intra Cellular Therapies (ITCI)
Arcutis Biotherapeutics (ARQT)
Ultragenyx Pharmaceutical (RARE)
Meta Platforms Cl A (META)
Arcellx Common Stock (ACLX)
UnitedHealth (UNH)
Apple (AAPL)
Amazon (AMZN)
89bio (ETNB)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Advanced Micro Devices (AMD)

View all positions for Suvretta Capital Management

Top funds holding Crh

Vanguard Group
BlackRock
BlackRock
Franklin Resources
Royal Bank of Canada
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Cevian Capital II GP
State Street Corporation
Select Equity
Greenhaven Associates
Invesco
Goldman Sachs Group
Robeco Investment Management
Geode Capital Management
Bank of New York Mellon

View all funds holding Crh